Boston Scientific
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Boston Scientific's balance sheet done over the years? Its assets were worth $35,136,000,000 last year, which is more than in the previous period. 44% of Boston Scientific’s total assets is currently financed by debt. Its liabilities reached the amount of $15,606,000,000, which means an increase by 5% compared compared to last year.
Debt to Assets
| 2014 | 16830000000 | 9.98B | 59.34% |
|---|---|---|---|
| 2015 | 18133000000 | 11.81B | 65.15% |
| 2016 | 18096000000 | 11.36B | 62.79% |
| 2017 | 19041000000 | 12.03B | 63.18% |
| 2018 | 20998000000 | 12.27B | 58.45% |
| 2019 | 30565000000 | 16.68B | 54.6% |
| 2020 | 30778000000 | 15.45B | 50.2% |
| 2021 | 32230000000 | 15.60B | 48.42% |
| 2022 | 32470000000 | 14.89B | 45.88% |
| 2023 | 35136000000 | 15.60B | 44.42% |
BSX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 865M | 928M | 1.92B | 1.73B | 217M | 146M | 188M | 196M | 319M | 587M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3M |
Net receivables | 2.22B | 1.97B | 1.77B | 1.53B | 1.93B | 1.60B | 1.54B | 1.47B | 1.27B | 1.18B |
Inventory | 2.48B | 1.86B | 1.61B | 1.35B | 1.57B | 1.16B | 1.07B | 955M | 1.01B | 946M |
Other current assets | 937M | 350M | 385M | 410M | 324M | 922M | 1.00B | 541M | 918M | 890M |
Total current assets | 6.51B | 5.76B | 6.31B | 6.69B | 4.69B | 4.00B | 3.82B | 3.23B | 3.47B | 3.39B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 3.29B | 2.83B | 2.68B | 2.54B | 2.41B | 1.78B | 1.69B | 1.63B | 1.49B | 1.50B |
Goodwill | 14.38B | 12.92B | 11.98B | 9.95B | 10.17B | 7.91B | 6.99B | 6.67B | 6.47B | 5.89B |
Intangible assets | 6.00B | 5.90B | 6.12B | 5.91B | 7.88B | 6.37B | 5.83B | 5.88B | 6.19B | 5.60B |
Long term investments | 413M | 407M | 412M | 918M | 458M | -328M | -191M | -75M | -496M | -447M |
Other non-current assets | 680M | 707M | 563M | 545M | 735M | 932M | 688M | 666M | 505M | 425M |
Total non-current assets | 28.62B | 26.71B | 25.91B | 24.08B | 25.86B | 16.99B | 15.21B | 14.85B | 14.66B | 13.43B |
Total assets | 35.13B | 32.47B | 32.23B | 30.77B | 30.56B | 20.99B | 19.04B | 18.09B | 18.13B | 16.83B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 266M | 220M | 208M | 138M | 144M | 328M | 191M | 75M | 496M | 447M |
Short term debt | 531M | 20M | 261M | 13M | 1.41B | 2.25B | 1.80B | 64M | 3M | 403M |
Total current liabilities | 4.93B | 3.80B | 4.27B | 3.68B | 4.86B | 5.26B | 5.65B | 3.58B | 2.43B | 2.24B |
| Non-current liabilities: | ||||||||||
Long term debt | 8.96B | 9.26B | 9.19B | 9.52B | 8.86B | 4.77B | 3.81B | 5.42B | 5.67B | 3.84B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 1.26B | 1.39B | 1.55B | 1.65B | 1.16B | 717M | 2.36B | 2.33B | 2.97B | 2.66B |
Total non-current liabilities | 10.67B | 11.09B | 11.33B | 11.77B | 11.82B | 7.01B | 6.37B | 7.77B | 9.38B | 7.74B |
Total liabilities | 15.60B | 14.89B | 15.60B | 15.45B | 16.68B | 12.27B | 12.03B | 11.36B | 11.81B | 9.98B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |